JP7870919B2 - 人工rna分子 - Google Patents

人工rna分子

Info

Publication number
JP7870919B2
JP7870919B2 JP2024519192A JP2024519192A JP7870919B2 JP 7870919 B2 JP7870919 B2 JP 7870919B2 JP 2024519192 A JP2024519192 A JP 2024519192A JP 2024519192 A JP2024519192 A JP 2024519192A JP 7870919 B2 JP7870919 B2 JP 7870919B2
Authority
JP
Japan
Prior art keywords
sequence
mrna
polynucleotide
rna molecule
exon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2024519192A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023214512A1 (cg-RX-API-DMAC10.html
JPWO2023214512A5 (cg-RX-API-DMAC10.html
Inventor
玲 芳本
真一 中川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hokkaido University
Josho Gakuen Educational Foundation
Original Assignee
Hokkaido University
Josho Gakuen Educational Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokkaido University, Josho Gakuen Educational Foundation filed Critical Hokkaido University
Publication of JPWO2023214512A1 publication Critical patent/JPWO2023214512A1/ja
Publication of JPWO2023214512A5 publication Critical patent/JPWO2023214512A5/ja
Application granted granted Critical
Publication of JP7870919B2 publication Critical patent/JP7870919B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/33—Alteration of splicing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2024519192A 2022-05-06 2023-04-20 人工rna分子 Active JP7870919B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022076674 2022-05-06
JP2022076674 2022-05-06
PCT/JP2023/015828 WO2023214512A1 (ja) 2022-05-06 2023-04-20 人工rna分子

Publications (3)

Publication Number Publication Date
JPWO2023214512A1 JPWO2023214512A1 (cg-RX-API-DMAC10.html) 2023-11-09
JPWO2023214512A5 JPWO2023214512A5 (cg-RX-API-DMAC10.html) 2025-01-20
JP7870919B2 true JP7870919B2 (ja) 2026-06-08

Family

ID=88646433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519192A Active JP7870919B2 (ja) 2022-05-06 2023-04-20 人工rna分子

Country Status (4)

Country Link
US (1) US20250297253A1 (cg-RX-API-DMAC10.html)
EP (1) EP4520825A4 (cg-RX-API-DMAC10.html)
JP (1) JP7870919B2 (cg-RX-API-DMAC10.html)
WO (1) WO2023214512A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025217551A1 (en) * 2024-04-12 2025-10-16 University Of Miami Microrna-mediated obstruction of stem-loop alternative splicing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013521791A (ja) 2010-03-17 2013-06-13 アソシアシオン インスティテュト ドゥ ミョロジー 神経筋疾患の治療のための修飾型U7snRNA
JP2019519218A (ja) 2016-05-18 2019-07-11 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. 調節性ポリヌクレオチド
WO2021117729A1 (ja) 2019-12-09 2021-06-17 アステラス製薬株式会社 標的rnaを編集するための機能性領域を付加したアンチセンス型ガイドrna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI541024B (zh) 2010-09-01 2016-07-11 日本新藥股份有限公司 反義核酸
MX2018007987A (es) 2015-12-28 2019-01-10 Novartis Ag Composiciones y metodos para el tratamiento de hemoglobinopatias.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013521791A (ja) 2010-03-17 2013-06-13 アソシアシオン インスティテュト ドゥ ミョロジー 神経筋疾患の治療のための修飾型U7snRNA
JP2019519218A (ja) 2016-05-18 2019-07-11 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. 調節性ポリヌクレオチド
WO2021117729A1 (ja) 2019-12-09 2021-06-17 アステラス製薬株式会社 標的rnaを編集するための機能性領域を付加したアンチセンス型ガイドrna

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Fumio HARADA et al.,Nucleotide sequences of 4.5S RNAs associated with poly (A) -containing RNAs of mouse and hamster cells,Nucleic Acids Research,1980年,Vol. 8,No. 6,p.1273-1286,DOI: 10.1093/nar/8.6.1273
ISHIDA, Kentaro et al.,Regulation of gene expression via retrotransposon insertions and the noncoding RNA 4.5S RNAH,Genes to Cells,2015年09月03日,Vol.20, No.11,pp.887-901

Also Published As

Publication number Publication date
EP4520825A4 (en) 2026-05-27
JPWO2023214512A1 (cg-RX-API-DMAC10.html) 2023-11-09
WO2023214512A1 (ja) 2023-11-09
US20250297253A1 (en) 2025-09-25
EP4520825A1 (en) 2025-03-12

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241105

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241105

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20241105

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20241204

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20241203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250930

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260410

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260512

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260518

R150 Certificate of patent or registration of utility model

Ref document number: 7870919

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150